Quantcast
Home / Columnists / Berko / BERKO: Stock may gain if customers lose double chins (access required)

BERKO: Stock may gain if customers lose double chins (access required)

DEAR MR. BERKO: What are your thoughts on Kythera Biopharmaceuticals? My family doctor, a brilliant clinician, told me Kythera has an injectable that will eliminate my double chin, to be available early next year. I'd like to invest $10,000 if you believe that this company has a chance for success. – JF, Vancouver, Wash. DEAR JF: ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*